Mobile EHR startup DrChrono raises $12M, plans to build out telehealth features

  After launching a telehealth feature for its users earlier this year, health records startup DrChrono plans to build it out with $12 million in funding. The company recently raised a growth capital round led by ORIX Growth Capital, which led a debt financing for DrChrono last year.  After a challenging year for DrChrono’s...

Third Rock-backed Abata gets $95M to take cell therapy to MS, other autoimmune diseases

  Imagine an autoimmune disease treatment that activates only at the site of disease, shuts down inflammation from multiple sources, promotes tissue repair, and lasts for years. The source of this therapy, a type of immune cell, is already inside each and every one of us. Biotech startup Abata Therapeutics has raised $95 million...

Remote Patient Monitoring: Coming of age in an AI-driven world

Remote patient monitoring (RPM) is quickly establishing itself as one of the most effective tools for chronic disease management. RPM is the collection and transmission of patient health data to providers via connected devices outside of a conventional care setting. These monitoring devices record vital information, such as blood pressure, heart rate, or...

Register now for INVEST Digital Health September 21-23

The agenda for INVEST Digital Health, scheduled for September 21-23, reflects the diverse conversations happening in this sector, from AI to reimbursement to investment trends. Of course, digital health startups will take center stage with three tracks of the Pitch Perfect contest spanning Home Health, Chronic Disease Management and Value-based Care as well...

Pear Therapeutics plans to go public in $1.6B SPAC deal

With three FDA-cleared products on the market, and many more in its pipeline, Pear Therapeutics has solved one of the early puzzles of digital therapeutics: getting the green light from regulators for its software to be prescribed as a treatment. Now, the Boston-based startup is making plans to go public as it figures out...